Neuraltus Pharmaceuticals

Neuraltus Pharmaceuticals

Neuraltus Pharmaceuticals

Neuraltus Pharmaceuticals is focused on developing therapeutics that meetcritical unmet needs in treating neurodegenerative diseases.
Raised
$43M
Follow us
Alexa global traffic share
Latest funding Show all
$14,940,000
Venture capital (Series UNDISCLOSED) - 2016
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Neuraltus Pharmaceuticals makes some noise.